Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.08%177.981.3%$463.11m
CELGCelgene Corporation
0.91%97.391.3%$421.94m
GILDGilead Sciences, Inc.
1.31%67.230.9%$393.59m
BIIBBiogen Inc.
2.23%232.751.3%$355.28m
ILMNIllumina, Inc.
2.11%351.273.5%$273.61m
REGNRegeneron Pharmaceuticals, Inc.
1.91%311.082.6%$233.37m
AAgilent Technologies, Inc.
0.63%70.411.6%$213.41m
VRTXVertex Pharmaceuticals Incorporated
2.23%174.021.9%$198.52m
ARRYArray BioPharma Inc.
57.10%46.498.2%$186.25m
EXASExact Sciences Corporation
0.94%110.8125.3%$184.59m
ALXNAlexion Pharmaceuticals, Inc.
2.26%120.592.0%$176.05m
BMRNBioMarin Pharmaceutical Inc.
4.15%84.204.3%$136.24m
MRTXMirati Therapeutics Inc.
6.91%100.772.5%$114.41m
IONSIonis Pharmaceuticals, Inc.
4.43%64.848.2%$97.22m
INCYIncyte Corporation
5.52%82.002.5%$92.12m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.